Induction of tolerance to mouse skin allograft by donor bone marrow-derived immature dendritic cells combined with rapamycin
余思, 付必莽, 何晓顺, 胡安斌, 马毅, 黄洁夫
Abstract
余思, 付必莽, 何晓顺, 胡安斌, 马毅, 黄洁夫
Abstract
Objective To investigate the synergic effects of donor bone marrow-derived immature dendritic cells combined with rapamycin on induction of tolerance to skin allograft in mice. Methods An allogenic skin transplantation model was established with the donors C57BL/6 mice and the recipients BALB/C mice. Recipients were divided into 4 groups : control group ( no administration before or after skin transplantation) , rapamycin group (receiving rapamycin 1 mg/kg^-1·d^-1 by garage for consecutive 7 days after skin transplantation) ,immature DC group (receiving an injection of donor bone marrow-derived immature DC via tail vein before skin transplantation), combined group (receiving an injection of donor bone marrow-derived immature DC via tail vein before transplantation and rapamycin 1 mg/kg^-1·d^-1 by garage for consecutive 7 days after transplantation). The survival time of skin allograft was observed. Results The survival time of skin allograft in the groups of control, rapamycin, immature DC, and immature DC ± rapamyein was (6.9 ± 1.9 ), ( 10.3 ± 3.0), ( 17.0 ± 3.4 ), and ( 20.8 ± 3.6 ) days respectively. Statistical analysis showed that there was significant difference among groups ( P 〈 0.05 ) ; Furthermore, S-N-K test showed that there was significant difference between every two groups. Conclusion There were synergic effects for donor bone marrow-derived immature dendritic cells and rapamycin in induction of tolerance to skin allograft in mice. Key words: Dendritic cells; Rapamyein; Immune tolerance; Skin transplantation
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the synergic effects of donor bone marrow-derived immature dendritic cells combined with rapamycin on induction of tolerance to skin allograft in mice. Methods An allogenic skin transplantation model was established with the donors C57BL/6 mice and the recipients BALB/C mice. Recipients were divided into 4 groups : control group ( no administration before or after skin transplantation) , rapamycin group (receiving rapamycin 1 mg/kg^-1·d^-1 by garage for consecutive 7 days after skin transplantation) ,immature DC group (receiving an injection of donor bone marrow-derived immature DC via tail vein before skin transplantation), combined group (receiving an injection of donor bone marrow-derived immature DC via tail vein before transplantation and rapamycin 1 mg/kg^-1·d^-1 by garage for consecutive 7 days after transplantation). The survival time of skin allograft was observed. Results The survival time of skin allograft in the groups of control, rapamycin, immature DC, and immature DC ± rapamyein was (6.9 ± 1.9 ), ( 10.3 ± 3.0), ( 17.0 ± 3.4 ), and ( 20.8 ± 3.6 ) days respectively. Statistical analysis showed that there was significant difference among groups ( P 〈 0.05 ) ; Furthermore, S-N-K test showed that there was significant difference between every two groups. Conclusion There were synergic effects for donor bone marrow-derived immature dendritic cells and rapamycin in induction of tolerance to skin allograft in mice. Key words: Dendritic cells; Rapamyein; Immune tolerance; Skin transplantation
Key concepts: Transplantation, Bone marrow, Medicine, Immune tolerance, Immune system, Dendritic cell, Andrology, Immunology